Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico

Silvia Núñez-Fernández, Diego Rivera, Eva María Arroyo-Anlló, Xóchitl Angélica Ortiz Jiménez, Borja Camino-Pontes, Ricardo Salinas Martínez and Juan Carlos Arango-Lasprilla ()
Additional contact information
Silvia Núñez-Fernández: Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain
Diego Rivera: Department of Health Sciences, Public University of Navarre, 31006 Pamplona, Spain
Eva María Arroyo-Anlló: Department of Psychobiology, Neuroscience Institute of Castilla-León, University of Salamanca, 37007 Salamanca, Spain
Xóchitl Angélica Ortiz Jiménez: Faculty of Psychology, Autonomous University of Nuevo León, Monterrey 64460, Mexico
Borja Camino-Pontes: Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain
Ricardo Salinas Martínez: Department of Geriatrics, “José Eleuterio González” University Hospital, Autonomous University of Nuevo León, Monterrey 64460, Mexico
Juan Carlos Arango-Lasprilla: Department of Psychology, Virginia Commonwealth University Richmond, Richmond, VA 23284, USA

IJERPH, 2022, vol. 19, issue 18, 1-15

Abstract: To our knowledge, this is the first study reported in the literature that has validated the Norma Latina Battery in a population of people with Alzheimer’s disease (AD) in Mexico. The objective of the study was to determine the discriminant validity of the Norma Latina Battery in a group of Mexican individuals with AD and a group of heathy controls (HC). The Norma Latina Battery was administered to 234 Mexican participants (117 HC and 117 individuals with AD). Results show that: (1) the Norma Latina Battery has high discriminative capacity between groups in all domains; (2) participants with AD presented worse scores in each of the cognitive domains compared to the HC and a greater number of low scores in each of the established thresholds or cut-off points; and finally, (3) the Norma Latina Battery had optimal sensitivity and specificity, especially when a set was observed ≥5 scores below the 10th percentile or ≥4 scores below the 5th percentile. In conclusion, it is recommended that both clinicians and researchers use this battery in the evaluation of Mexican people with AD to better understand the prognosis of the disease and its subsequent treatment.

Keywords: Alzheimer’s disease; neuropsychological assessment; cognitive problems; Latin America; Mexico (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/18/11322/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/18/11322/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:18:p:11322-:d:910442

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().